Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Consumer Cyclical Companies: Petco Health and Wellness Company (WOOF) and Bayerische Motoren Werke Aktiengesellschaft (OtherBAMXF)

Tipranks - Fri Mar 13, 6:26AM CDT

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Petco Health and Wellness Company (WOOFResearch Report) and Bayerische Motoren Werke Aktiengesellschaft (BAMXFResearch Report).

Claim 70% Off TipRanks Premium

Petco Health and Wellness Company (WOOF)

Guggenheim analyst Steven Forbes maintained a Hold rating on Petco Health and Wellness Company today. The company’s shares closed last Wednesday at $2.40.

According to TipRanks.com, Forbes is a 4-star analyst with an average return of 8.9% and a 51.9% success rate. Forbes covers the NA sector, focusing on stocks such as SharkNinja, Inc., Tractor Supply, and Home Depot. ;'>

Currently, the analyst consensus on Petco Health and Wellness Company is a Moderate Buy with an average price target of $3.75, representing a 58.9% upside. In a report released today, Morgan Stanley also maintained a Hold rating on the stock with a $3.75 price target.

See the top stocks recommended by analysts >>

Bayerische Motoren Werke Aktiengesellschaft (BAMXF)

In a report released today, Christian Frenes from Goldman Sachs maintained a Buy rating on Bayerische Motoren Werke Aktiengesellschaft, with a price target of EUR105.00. The company’s shares closed last Tuesday at $92.51.

According to TipRanks.com, Frenes is a 1-star analyst with an average return of -7.4% and a 0.0% success rate. Frenes covers the NA sector, focusing on stocks such as Mercedes-Benz Group, Stellantis, and Ferrari. ;'>

Currently, the analyst consensus on Bayerische Motoren Werke Aktiengesellschaft is a Hold with an average price target of $107.02, which is a 15.7% upside from current levels. In a report issued on March 2, J.P. Morgan also maintained a Buy rating on the stock with a EUR100.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.